IP Library › Granted Patent US 10,689,682
Granted Patent B2
US 10,689,682 · App. 16/538,046 · Granted Jun 23, 2020

Mogrol glycosyltransferase and gene encoding same

Inventors: Eiichiro Ono (Kyoto, JP); Misa Ochiai (Kyoto, JP)
Assignee: SUNTORY HOLDINGS LIMITED
C12P33/20C07J9/00C07J17/005C12N1/16C12N1/20C12N15/52C12N15/63C12P19/18C12P19/56C12P33/00C12Y204/01
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,689,682
App. No.
16/538,046
Granted
Jun 23, 2020
Kind
B2
Abstract

To provide a mogrol glycosyltransferase and a method for producing a mogrol glycoside using the enzyme. The present invention provides a mogrol glycosyltransferase and a method for producing a mogrol glycoside using the enzyme, and a transformant into which a mogrol glycosyltransferase gene is introduced and a method for preparing the transformant.

Claims (33)

1. A polynucleotide selected from:

(a) a polynucleotide comprising the nucleotide sequence of SEQ ID NO: 1;

(b) a polynucleotide comprising a heterologous regulatory element operably linked to a polynucleotide sequence encoding a protein consisting of the amino acid sequence of SEQ ID NO: 2; and

(c) a polynucleotide encoding a protein consisting of an amino acid sequence in which 1 to 45 amino acids are deleted, substituted, inserted, and/or added in the amino acid sequence of SEQ ID NO: 2 and having an activity of adding a sugar molecule to an R 1 group at position 24 of a compound represented by the formula (I)

where R and R 1 each independently represent H, a monosaccharide, or a disaccharide.

2. A protein consisting of an amino acid sequence in which 1 to 45 amino acids are deleted, substituted, inserted, and/or added in the amino acid sequence of SEQ ID NO: 2 and having an activity of adding a sugar molecule to an R1 group at position 24 of a compound represented by formula (I)

where R and R 1 each independently represent H, a monosaccharide, or a disaccharide.

3. A vector comprising the polynucleotide of claim 1 .

4. A non-human transformant comprising the polynucleotide of claim 1 .

5. The non-human transformant of claim 4 , which is a plant or a microorganism.

6. The non-human transformant of claim 4 , wherein the polynucleotide is inserted into an expression vector.

7. A method comprising culturing or cultivating the non-human transformant of claim 4 to produce the protein consisting of the amino acid sequence of SEQ ID NO: 2.

8. The method of claim 7 , further comprising:

producing a mogrol glycoside by reacting the protein consisting of the amino acid sequence of SEQ ID NO: 2 produced by the non-human transformant with a UDP-sugar and a compound represented by formula (I):

where R and R 1 each independently represent H, a monosaccharide, or a disaccharide.

9. A method of producing a mogrol glycoside, comprising:

reacting in vitro a protein consisting of the amino acid sequence of SEQ ID NO: 2 with a UDP-sugar and a compound represented by formula (I):

where R and R 1 each independently represent H, a monosaccharide, or a disaccharide.

10. A method comprising:

providing the non-human transformant of claim 4 or a culture thereof, and

obtaining an extract of the non-human transformant or of the culture of the non-human transformant.

11. A method comprising:

providing an extract of the non-human transformant of claim 4 or an extract of a culture of the non-human transformant of claim 4 ,

adding the extract to a raw material of a food, a pharmaceutical preparation or an industrial raw material, and

preparing a food, a pharmaceutical preparation or an industrial raw material.

12. The method of claim 8 , wherein the UDP-sugar is a UDP-hexose.

13. The method of claim 8 , wherein the sugar molecule is selected from the group consisting of UDP-glucose, UDP-mannose, and UDP-galactose.

14. The method of claim 8 , wherein R and R 1 is each independently H or a sugar residue of a glucose monomer or a glucose dimer.

15. The method of claim 8 , wherein the compound represented by formula (I) is mogrol or a mogrol glycoside.

16. The method of claim 8 , wherein the mogrol glycoside is mogroside IA, mogroside Ib, mogroside IE, mogroside IIA, mogroside IIA1, mogroside IIE, mogroside III, mogroside IIIA1, mogroside IIIA2, mogroside IIIE, mogroside IV, mogroside IVA, mogroside V, siamenoside I, 11-oxomogroside V, mogrol pentaglycoside, or a combination thereof.

17. The method of claim 9 , wherein the mogrol glycoside is mogroside IA, mogroside Ib, mogroside IE, mogroside IIA, mogroside IIA1, mogroside IIE, mogroside III, mogroside IIIA1, mogroside IIIA2, mogroside IIIE, mogroside IV, mogroside IVA, mogroside V, siamenoside I, 11-oxomogroside V, mogrol pentaglycoside, or a combination thereof.

18. The method of claim 11 , wherein the food is a beverage.

19. The method of claim 11 , wherein the food is selected from a juice drink, a soft drink, a sports beverage, an alcoholic beverage, a tea, a vinegar, and a soy sauce.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 12, 2019
From: ONO, EIICHIRO; OCHIAI, MISA
To: SUNTORY HOLDINGS LIMITED
Reel/Frame 050026/0044 →
Priority Claims (1)
JP 2014-213063 · Oct 17, 2014 · national
Continuity (2)
Continuation 15519326
Related Publication 20190367961A1 · Dec 5, 2019
Cited By (1)
US 12,234,464